Single-cell RNA-seq reveals activation of unique gene groups as a consequence of stem cell-parenchymal cell fusion

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Freeman, Brian T ^a,b,c   Jung, Jangwook P ^a,b   Ogle, Brenda M ^a,b,c,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c University of Wisconsin Madison   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ANIMAL; CELL CULTURE; CELL FUSION; CYTOLOGY; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; MOUSE; PARENCHYMA; PHYSIOLOGY; SEQUENCE ANALYSIS; SINGLE CELL ANALYSIS; TRANSCRIPTION INITIATION;

ANIMALS; CELL FUSION; CELLS, CULTURED; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; PARENCHYMAL TISSUE; SEQUENCE ANALYSIS, RNA; SINGLE-CELL ANALYSIS; TRANSCRIPTIONAL ACTIVATION; TRANSCRIPTOME;

EID: 84961778087     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23270     Document Type: Article

References (53)

1. Alvarez-Dolado, M. et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425, 968-973 (2003).
2. Wang, X. et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422, 897-901 (2003).
3. Rizvi, A. Z. et al. Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci USA 103, 6321-6325 (2006).
4. Andrade, J. et al. Predominant fusion of bone marrow-derived cardiomyocytes. Cardiovasc Res 68, 387-393 (2005).
5. Kruglyakov, P. V. et al. In vitro and in vivo differentiation of mesenchymal stem cells in the cardiomyocyte direction. B Exp Biol Med 142, 503-506 (2006).
6. Noiseux, N. et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther 14, 840-850 (2006).
7. Nygren, J. M. et al. Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat Cell Biol 10, 584-592 (2008).
8. Oh, H. et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 100, 12313-12318 (2003).
9. Freeman, B. T., Kouris, N. A., Ogle, B. M. Tracking fusion of human mesenchymal stem cells after transplantation to the heart. Stem Cells Transl Med 4, 685-694 (2015).
10. McDonald, D. M., Foss, A. J. Endothelial cells of tumor vessels: abnormal but not absent. Cancer Metastasis Rev 19, 109-120 (2000).
11. Morikawa, S. et al. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 160, 985-1000 (2002).
12. Mondal Roy, S., Sarkar, M. Membrane fusion induced by small molecules and ions. J Lipids 2011, 528784 (2011).
13. Paltsyn, A. A. et al. Intermittent hypoxia stimulates formation of binuclear neurons in brain cortex-a role of cell fusion in neuroprotection? Exp Biol Med (Maywood) 239, 595-600 (2014).
14. Lazova, R., Chakraborty, A., Pawelek, J. M. Leukocyte-cancer cell fusion: initiator of the warburg effect in malignancy? Adv Exp Med Biol 714, 151-172 (2011).
15. Duelli, D., Lazebnik, Y. Cell-to-cell fusion as a link between viruses and cancer. Nature Rev Cancer 7, 968-976 (2007).
16. Kouris, N. A. et al. Directed Fusion of Mesenchymal Stem Cells with Cardiomyocytes via VSV-G Facilitates Stem Cell Programming. Stem Cells Int 2012, 414038 (2012).
17. Kouris, N. A. et al. A nondenatured, noncrosslinked collagen matrix to deliver stem cells to the heart. Reg Med 6, 569-582 (2011).
18. Clavel, F., Charneau, P. Fusion from without directed by human immunodeficiency virus particles. J Virol 68, 1179-1185 (1994).
19. Joag, S. V. et al. Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J Virol 70, 3189-3197 (1996).
20. Karlsson, G. B. et al. The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simianhuman immunodeficiency virus-infected macaques. J Exp Med 188, 1159-1171 (1998).
21. Kondo, N., Marin, M., Kim, J. H., Desai, T. M., Melikyan, G. B. Distinct requirements for HIV-cell fusion and HIV-mediated cellcell fusion. J Biol Chem 290, 6558-6573 (2015).
22. Gao, P., Zheng, J. High-risk HPV E5-induced cell fusion: a critical initiating event in the early stage of HPV-associated cervical cancer. Virology J 7, 238 (2010).
23. Hu, L. et al. Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion. Virology 384, 125-134 (2009).
24. Lagasse, E. et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6, 1229-1234 (2000).
25. Willenbring, H. et al. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med 10, 744-748 (2004).
26. Miller, R. A., Ruddle, F. H. Pluripotent teratocarcinoma-thymus somatic cell hybrids. Cell 9, 45-55 (1976).
27. Cowan, C. A., Atienza, J., Melton, D. A., Eggan, K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309, 1369-1373 (2005).
28. Tada, M., Tada, T., Lefebvre, L., Barton, S. C., Surani, M. A. Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J 16, 6510-6520 (1997).
29. Palermo, A. et al. Nuclear reprogramming in heterokaryons is rapid, extensive, and bidirectional. FASEB J 23, 1431-1440 (2009).
30. Terada, N. et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416, 542-545 (2002).
31. Wei, H. J. et al. FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells. Oncotarget 5, 9514-9529 (2014).
32. Shadrin, I. Y., Yoon, W., Li, L., Shepherd, N., Bursac, N. Rapid fusion between mesenchymal stem cells and cardiomyocytes yields electrically active, non-contractile hybrid cells. Sci Rep 5, 12043 (2015).
33. Milstein, C., Cuello, A. C. Hybrid hybridomas and their use in immunohistochemistry. Nature 305, 537-540 (1983).
34. Lindner, M., Schirrmacher, V. Tumour cell-dendritic cell fusion for cancer immunotherapy: comparison of therapeutic efficiency of polyethylen-glycol versus electro-fusion protocols. Eur J Clin Invest 32, 207-217 (2002).
35. Willenbring, H., Grompe, M. Delineating the hepatocyte's hematopoietic fusion partner. Cell Cycle 3, 1489-1491 (2004).
36. van Berlo, J. H. et al. c-kit+ cells minimally contribute cardiomyocytes to the heart. Nature 509, 337-341 (2014).
37. Dittmar, T. et al. Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells. Clin Exp Metastasis 28, 75-90 (2011).
38. Ozel, C. et al. Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show a differential RAF-AKT crosstalk. Cell Comm Signal 10, 10 (2012).
39. Lu, X., Kang, Y. Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc Natl Acad Sci USA 106, 9385-9390 (2009).
40. Yang, J. Y., Ha, S. A., Yang, Y. S., Kim, J. W. p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance. BMC Cancer 10, 388 (2010).
41. Jacobsen, B. M. et al. Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epithelium. Cancer Res 66, 8274-8279 (2006).
42. Noubissi, F. K., Harkness, T., Alexander, C. M., Ogle, B. M. Apoptosis-induced cancer cell fusion: a mechanism of breast cancer metastasis. FASEB J 29, 4036-45 (2015).
43. Berndt, B. et al. Fusion of CCL21 non-migratory active breast epithelial and breast cancer cells give rise to CCL21 migratory active tumor hybrid cell lines. PLoS One 8, e63711 (2013).
44. Lin, H. P., Vincenz, C., Eliceiri, K. W., Kerppola, T. K., Ogle, B. M. Bimolecular fluorescence complementation analysis of eukaryotic fusion products. Biol Cell 102, 525-537 (2010).
45. Stegle, O., Teichmann, S. A., Marioni, J. C. Computational and analytical challenges in single-cell transcriptomics. Nature Rev Genetics 16, 133-145 (2015).
46. Kharchenko, P. V., Silberstein, L., Scadden, D. T. Bayesian approach to single-cell differential expression analysis. Nat Methods 11, 740-742 (2014).
47. van Riggelen, J., Yetil, A., Felsher, D. W. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 10, 301-309 (2010).
48. Orsolic, I. et al. The relationship between the nucleolus and cancer: Current evidence and emerging paradigms. Sem Cancer Bio S1044-579X (2015).
49. Grun, D., Kester, L., van Oudenaarden, A. Validation of noise models for single-cell transcriptomics. Nat Methods 11, 637-640 (2014).
50. Feng, W. et al. Targeting unique metabolic properties of breast tumor initiating cells. Stem Cells 32, 1734-1745 (2014).
51. Pavlath, G. K., Blau, H. M. Expression of muscle genes in heterokaryons depends on gene dosage. J Cell Biol 102, 124-130 (1986).
52. Trivedi, P., Hematti, P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol 36, 350-359 (2008).
53. Steinhelper, M. E. et al. Proliferation in vivo and in culture of differentiated adult atrial cardiomyocytes from transgenic mice. Am J Physiol 259, H1826-1834 (1990).